BRIEF-Coherus Biosciences announces positive topline Phase III results for CHS-1420
August 08, 2016 at 09:05 AM EDT
* Coherus Biosciences announces positive topline phase three results for chs-1420 (humira biosimilar candidate) in patients with psoriasis